Dow climbs 400 points as COVID-19 drug hopes outweigh economic pain

· *US equities soared on Wednesday as traders gained new hope from a successful coronavirus drug trial.*
· *Gilead announced Wednesday morning its remdesivir compound succeeded in a key trial. Additional information on the study will be released later in the day.*
· *Investors' optimism toward the positive drug news...